Co-founder in Residence, Insecticides and Pest Control

🕒 il y a 3 mois

🇬🇧 Royaume-Uni – Télétravail

💵 £5 000 / mois

⏰ Temps Plein

🟡 Intermédiaire

🟠 Senior

🇬🇧 Parrain de Visa de Travailleur Qualifié UK

Cette entreprise a parrainé des visas de Travailleur Qualifié du Royaume-Uni par le passé.

👻 Score fantôme 37%

Ce que ça veut dire : la probabilité que cette offre reste ouverte sans recrutement actif.Comment le lire : 60 % ou plus, on pense que c'est une offre fantôme. Un score plus bas est moins inquiétant.Comment on la calcule : ancienneté, republications, postes ouverts vs taille de l'équipe, rapidité de clôture, et si le salaire est indiqué.À noter : une estimation à partir de données publiques, pas un jugement sur l'entreprise. De vraies offres peuvent avoir un score élevé, alors prenez-le comme un indice, pas comme un fait.

Postuler Maintenant

Trouver des Emplois à Distance Similaires

Configurer une alerte email pour les nouveaux emplois

📊 Vérifiez votre score de CV pour ce poste

Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

Télécharger le CV

Deep Science Ventures

Site WebLinkedInTous les Emplois

11 - 50 employés

🏥 Santé

🍽️ Alimentation et boissons

🔬 Science

Healthcare • Food & Beverage • Science

Deep Science Ventures est une entreprise de création de start-up qui combine les connaissances scientifiques disponibles avec des scientifiques de type fondateurs pour bâtir des start-ups à fort impact. La société se concentre sur quatre secteurs clés : l'agriculture, le calcul, le climat et la pharmacie. Elle vise à faire évoluer l'agriculture des pratiques extractives vers des pratiques régénératives, libérer des effets de levier computationnels, inverser le réchauffement climatique mondial et créer des thérapies pour guérir les maladies. Deep Science Ventures a lancé 42 entreprises, est impliqué dans 37 projets en développement et a attiré 160 millions de dollars de financement avec une valorisation de portefeuille de 430 millions de dollars.

Description

• Join us to build a new venture eliminating off-target toxicity from agrochemicals by scaling next generation insecticides and pest control. • We’re seeking an experienced entrepreneur to found and spin out a company with us focused on species-targeted, durable pest control without off-target ecological or human health impacts. The role is full-time, remote initially until venture incorporation and spin-out (circa end of Q1 2027), location TBD. • You will join DSV’s venture creation programme as a Co-founder-in-Residence and work closely with the DSV and Grantham Foundation teams to spin out the new company. During the programme you will refine, improve and complement existing scoping work on: • The technical thesis for pest control that is scalable, durable and effective without off-target effects (neglect and technical tractability); • Commercial neglect (IP strategy, differentiation, competition); • Value proposition (market, value capture, techno-economics); • Regulatory strategy & positioning; • Fundraising strategy & pitching; • Optimising company strategy for the most rapid and derisked path to Series A. • Preparation for Investment Committee (IC) will involve fulfilling our investment criteria, recruiting advisory and co-founding team members, and parallel fundraising for additional expansion funds. • Assuming success at IC, you will receive pre-seed investment from DSV and Grantham Foundation, and spinout the company in 2027. You and your co-founders will own a significant stake in the business and continue receiving support post-spinout.

🎯 Exigences

• You are highly motivated by unsolved challenges in insect pest control, and driven to challenge the status quo in agrochemicals. • You are impact driven, take the initiative, make things happen, and think from a first principles perspective to figure out what’s really needed. • You have clear entrepreneurial spirit and mindset, demonstrated through impactful innovation, and an ability to work in ambiguous, unstructured but fast-paced, demanding and pressurised environments. • Collaborative nature, with the ability to work effectively in cross-functional teams. • Previous Founder experience. • Previous C-suite experience. • Previous fundraising experience (from VCs). • Commercial & BD expertise (licensing, partnering, collaborations). • Strong track record of building and leading successful teams. • Preferred experience (nice-to-have) • Core science depth (PhD or equivalent industry R&D know-how) in genomics, molecular biology, entomology, plant pathology, virology (or similar), with breadth across technological areas relevant for next generation pest control such as: • Biological modes of action (e.g. RNA design, stability, formulation/delivery); • Behavioural and life cycle manipulations (e.g. semiochemicals biosynthesis/bioprocess scale-up, deployment/mating disruption); • Safer small molecule discovery and screening (e.g. molecular glues, PFAS replacement) • Microbial or in-plant expression of biocontrols (Bt and beyond); • IPM design & field implementation with measurable on-farm outcomes. • Translational execution: e.g. taking traits/actives from discovery to field efficacy, managing CRO/CDMO programs, building regulator/investor/customer-ready data packages; and/or partnership development (growers, CROs/CDMOs, suppliers) and scalable IP strategy. • Cross-functional ownership across: R&D - Product - Regulatory - IP, evidenced by shipped results (trial outcomes, submissions, patents, launches); and/or EPA/EU experience and GLP study planning/oversight; or design of pivotal field trials supporting registration.

🏖️ Avantages

• We provide optimised, purpose-built, proprietary tools, resources and processes to help create high-impact ventures from scratch, using our venture creation methodology. • DSV and Grantham Foundation's extensive network incl. leaders of biotech VCs, technical & commercial domain expertise, and wide-ranging portfolio company capabilities. • We jointly provide an initial £250k (~$340k / €290k) investment governed by our Investment Committee to incorporate the new venture and develop early proof-of-concept data that is often needed to attract high profile non-venture studio VCs. This funding is also key for obtaining grant funding, which often needs to be matched with private investment. • You and your co-founder(s) together will own the majority equity stake in the company. • We provide minimum guaranteed income of £4,166 per month (fixed), paid to each Founder as a consultancy fee until the company is launched and pre-seed investment is secured. • We provide continuous support post spin-out, including fundraising, commercial partnerships, recruitment and team-building (amongst other things). • Other Founders currently at DSV across sectors working collaboratively and supporting one another - a unique resource to draw on.